https:/#/nc.emagedd.www/ - Search

Články časopisu Ordinary disease –⁠ appendicitis

Author of the article: Karel Lukáš Source: Vnitřní lékařství | 7-8/2015 10. 9. 2015

Články časopisu Cutaneous Malignancies in Organ Transplant Recipients

Author of the article: M. Baláž, M. Tichý Source: Česko-slovenská dermatologie | 3/2025 15. 9. 2025

Články časopisu Re-irradiation in high-grade gliomas –⁠ a topic still under debate

Author of the article: C. C. Mirestean, R. I. Iancu, D. P. T. Iancu Source: Česká a slovenská neurologie a neurochirurgie | 2/2025 27. 5. 2025

Články časopisu HIRUDOTHERAPY IN RECONSTRUCTIVE SURGERY: CASE-REPORTS AND REVIEW

Author of the article: P. Heinz, P. Tvrdý, R. Pink, Z. Dvořák, P. Michl Source: Acta chirurgiae plasticae | 3-4/2020 17. 12. 2020

Články časopisu Paraneoplastic movement disorders

Author of the article: O. Shabatiuk, J. Necpál Source: Česká a slovenská neurologie a neurochirurgie | 3/2025 4. 8. 2025

Články časopisu Lichen Sclerosus. Review

Author of the article: J. Štork Source: Česko-slovenská dermatologie | 6/2020 8. 12. 2020

News “Clinical Research Bites” –⁠ 2026/1

The first “bites” of the year highlight, right at the start, the benefits of a month of alcohol abstinence. Alongside this, they move from the latest findings on outcomes of proton therapy for oropharyngeal cancer through predictors of dementia all the way to prodromal dreams.

Source: proLékaře.cz 8. 1. 2026

News Stem Cells Open the Door to New Treatment Possibilities for Multiple Sclerosis

Multiple sclerosis (MS) remains a daunting adversary for most patients. This disease, which affects the brain, spinal cord, and optic nerve, gradually damages the protective myelin sheath of neurons and, in many patients, leads to chronic neurological impairment. Although modern medications can slow the progression, a causal treatment is still lacking. One of the most promising avenues of the past decade is stem cell research —⁠ an approach considered experimental but opening the door to new, yet unexplored therapeutic possibilities.

Source: proLékaře.cz 17. 12. 2025

News Selecting from the Red Book CHS: What's New in This Year's Recommendations for the Diagnosis and Treatment of CLL?

Chronic lymphocytic leukemia (CLL) is the most common lymphoid malignancy in adults in Europe and North America. However, this field is experiencing very dynamic developments, both in terms of diagnosis and therapy. The biggest changes have occurred in treatment regimens, and recommendations for the therapy of relapsed or refractory CLL have also changed. Innovations have also emerged in prognostic examinations. As part of the update to the 'Red Book' by the Czech Hematological Society ČLS JEP (CHS), fresh recommendations concerning this disease were published in October 2023.

Source: Chronic Lymphocytic Leukemia 7. 12. 2023

News Pharmacological Profile of Mavacamten and Key Studies of Its Use in HCM Treatment

A new addition to the treatment options for hypertrophic cardiomyopathy, approved for use in European Union countries in June 2023, is the selective reversible cardiac myosin inhibitor mavacamten. The following review summarizes its fundamental pharmacological characteristics along with the results of several crucial clinical studies and highlights the potential integration of mavacamten into clinical practice.

Source: Hypertrophic Cardiomyopathy (HCM) 1. 11. 2023

News Etiology and Therapy of Dry Eye Syndrome in a Nutshell

Dry eye syndrome, the most common diagnosis in outpatient ophthalmology practice, is a multifactorial disease with varying severity of symptoms. It reduces the quality of life and can also affect the patient's visual functions. Therapy is individualized according to the primary trigger of the disease and aims to restore the homeostasis of the ocular surface and tear film. Due to the rapid pace of modernization associated with numerous extrinsic factors contributing to the development of dry eye syndrome, its incidence is rising, as well as the number of topical therapeutic options.

Source: Ophthalmologic Diseases 15. 2. 2023

News How to Reduce the Risk of Venous Thromboembolism in Users of Combined Hormonal Contraceptives?

The use of combined oral contraceptives (COCs) is a known risk factor for thromboembolism. Therefore, we should consider the individual risk of each patient before prescribing COCs. Women with a positive personal or family history of thromboembolic events should undergo molecular genetic testing for the presence of thrombophilic mutations.

Source: Genetics 27. 6. 2023

Články časopisu Using DNA barcoding to improve invasive pest identification at U.S. ports-of-entry

Author of the article: Mary J. L. Madden, Robert G. Young, John W. Brown, Scott E. Miller, Andrew J. Frewin, Robert H. Hanner Source: PLOS One | 9/2019 9. 9. 2019

Články časopisu Heat stress responses in a large set of winter wheat cultivars (Triticum aestivum L.) depend on the timing and duration of stress

Author of the article: Krisztina Balla, Ildikó Karsai, Péter Bónis, Tibor Kiss, Zita Berki, Ádám Horváth, Marianna Mayer, Szilvia Bencze, Ottó Veisz Source: PLOS One | 9/2019 9. 9. 2019

Články časopisu Why are Chinese workers so unhappy? A comparative cross-national analysis of job satisfaction, job expectations, and job attributes

Author of the article: Xing Zhang, Micha Kaiser, Peng Nie, Alfonso Sousa-Poza Source: PLOS One | 9/2019 9. 9. 2019